Latest News - Acquisitions/Mergers

Monday, April 10, 2017 | Acquisitions/Mergers

Cutting Edge Group SAS Acquires Kestrel Ophthalmics

Cutting Edge SAS announced it has signed a definitive agreement to acquire Kestrel Ophthalmics Limited, an ophthalmic distributor in the United Kingdom. Terms of the deal were not disclosed. Kes…

Read the full story

Friday, April 07, 2017 | Acquisitions/Mergers, Akorn Pharmaceuticals

Fresenius Considers Bid for Generic Drugmaker Akorn

Fresenius SE, Europe’s biggest publicly traded health-care provider, is weighing a bid for US generic drugmaker Akorn Inc., according to Bloomberg News, citing people familiar with the matter sa…

Read the full story

Friday, April 07, 2017 | Acquisitions/Mergers, Management/Leadership, Second Sight Medical Products

Second Sight Announces Dr. Robert Greenberg, Chairman, Inducted as a National Academy of Inventors Fellow

Second Sight Medical Products announced that Robert Greenberg, MD, PhD, Chairman, was inducted as a National Academy of Inventors (NAI) Fellow at a ceremony held at the Sixth Annual Conference of the …

Read the full story

Thursday, April 06, 2017 | Acquisitions/Mergers, Dry Eye, Imprimis Pharmaceuticals

Imprimis Pharmaceuticals Acquires Exclusive License to Patented Ophthalmic Formulation for Dry Eye Disease

Imprimis Pharmaceuticals announced that it has entered into an licensing agreement for the exclusive worldwide rights to Klarity, a patented ophthalmic topical solution and gel technology for patients…

Read the full story

Tuesday, March 14, 2017 | Acquisitions/Mergers, Allergan

Allergan and Editas Medicine Enter Strategic R&D Alliance to Discover and Develop CRISPR Genome Editing Medicines for Eye Diseases

Allergan and Editas Medicine, a genome editing company, announced that Allergan's wholly owned subsidiary, Allergan Pharmaceuticals International Limited, and Editas Medicine have entered into a s…

Read the full story

Friday, March 10, 2017 | Acquisitions/Mergers

Amring Pharmaceuticals Acquired Six ANDAs

Generic drug company Amring Pharmaceuticals announced that it acquired six ANDAs from Luitpold Pharmaceuticals and AlphaForce, LLP, a joint venture between Luitpold Pharmaceuticals and Alphagen Labora…

Read the full story

Thursday, March 02, 2017 | Acquisitions/Mergers

Guardion Health Sciences Signs Letter of Intent to Acquire VectorVision

Guardion Health Sciences has signed a letter of intent to acquire VectorVision in a stock exchange transaction. VectorVision is a provider of standardized vision testing, and a leader in the fie…

Read the full story

Monday, February 27, 2017 | Acquisitions/Mergers, Abbott Medical Optics, AMO, Johnson & Johnson Vision Care

Johnson & Johnson Completes Acquisition of Abbott Medical Optics

Johnson & Johnson announced that it has completed the acquisition of Abbott Medical Optics (AMO) in an all-cash deal worth $4.325 billion. The deal, which was originally announced September 16, 20…

Read the full story

Tuesday, February 21, 2017 | Acquisitions/Mergers, Eyegate Pharmaceuticals, Valeant

Valeant and Eyegate Enter into Licensing Agreement for EyeGate II Delivery System and EGP-437 Combination Product

Valeant Pharmaceuticals International and EyeGate Pharmaceuticals announced that they have entered into an exclusive, worldwide licensing agreement through which EyeGate has granted a subsidiary of Va…

Read the full story

Thursday, February 16, 2017 | Acquisitions/Mergers, Retina

BioTime Expands Ophthalmology Portfolio With Global In-Licensing Agreement for Next-Generation Retinal Disease Therapy From University of Pittsburgh

BioTime announced that the company has obtained a worldwide license to intellectual property (IP) assets from University of Pittsburgh. The technology was developed in part in collaboration with BioTi…

Read the full story

Monday, February 13, 2017 | Acquisitions/Mergers, Allergan

Allergan to Acquire Zeltiq, Maker of CoolSculpting System, for $2.47 Billion

Allergan has agreed to acquire Zeltiq Aesthetics for $56.50 per share, or $2.475 billion, subject to customary adjustments, the companies announced in a news release. T Allergan said the acquisitio…

Read the full story

Thursday, February 09, 2017 | Acquisitions/Mergers

Lions Eye Institute for Transplant & Research Doubles Its Size After Acquisition of International Sight Restoration

The Lions Eye Institute for Transplant & Research (LEITR) announced the acquisition of International Sight Restoration (ISR) in Tampa to double its size, creating one of the largest eye banks and …

Read the full story

Monday, February 06, 2017 | Acquisitions/Mergers, AMD

BioTime Expands Ophthalmology Portfolio With Global In-Licensing Agreement for Retinal Disease Therapy From University of Pittsburgh Medical Center

BioTime announced the acquisition of global rights to ophthalmology-related intellectual property assets from the University of Pittsburgh’s Medical Center (UPMC), via the school’s Innovat…

Read the full story

Thursday, January 26, 2017 | Acquisitions/Mergers, Johnson & Johnson Vision Care

Johnson & Johnson To Acquire Actelion For $30 Billion With Spin-Out Of New R&D Company

Johnson & Johnson, which in September agreed to acquire Abbott Medical Optics for $4.325 billion in cash, announced that it has agreed to acquired Actelion for $280 per share in cash, or $30 …

Read the full story

Tuesday, January 24, 2017 | Acquisitions/Mergers

Hilco Vision Announces the Acquisition of Croakies Inc.

Hilco Vision announced the acquisition of Croakies, the Wyoming-based originator of eyewear retainers and associated outdoor lifestyle accessories. Terms of the deal were not disclosed. "Hi…

Read the full story
Load More